Revolution Medicines, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for RVMD, updated each market day.
RVMD AI Sentiment
AI sees no strong directional signal for Revolution Medicines, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Revolution Medicines, Inc. Common Stock
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
Sector
Exchange
Market Cap
$19,068,244,259
Cap Tier
Employees
883
Headquarters
REDWOOD CITY, CA
Listed Since
Feb. 13, 2020
Website
RVMD Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
RVMD Volatility
Revolution Medicines, Inc. Common Stock has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
